Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial

BACKGROUND: Dose-escalation to above 80 Gy during external beam radiotherapy for localised prostate cancer leads to improved oncological outcomes but also substantially increased rectal toxicity. The aim of this study was to demonstrate the safety and efficacy of escalating the dose to 82 Gy followi...

Descripción completa

Detalles Bibliográficos
Autores principales: See, Andrew W., Bowden, Patrick, Wells, Geoffrey, Appu, Sree, Lawrentschuk, Nathan, Liodakis, Peter, Pandeli, Chloe, Aarons, Yolanda, Smyth, Lloyd M. L., McKenzie, Dean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316359/
https://www.ncbi.nlm.nih.gov/pubmed/35879722
http://dx.doi.org/10.1186/s13014-022-02103-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316359/
https://www.ncbi.nlm.nih.gov/pubmed/35879722
http://dx.doi.org/10.1186/s13014-022-02103-5

Ejemplares similares